These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7980110

  • 1. 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis.
    Polman CH, Bertelsmann FW, de Waal R, van Diemen HA, Uitdehaag BM, van Loenen AC, Koetsier JC.
    Arch Neurol; 1994 Nov; 51(11):1136-9. PubMed ID: 7980110
    [Abstract] [Full Text] [Related]

  • 2. 4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety.
    Polman CH, Bertelsmann FW, van Loenen AC, Koetsier JC.
    Arch Neurol; 1994 Mar; 51(3):292-6. PubMed ID: 8129642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.
    Bever CT, Young D, Anderson PA, Krumholz A, Conway K, Leslie J, Eddington N, Plaisance KI, Panitch HS, Dhib-Jalbut S.
    Neurology; 1994 Jun; 44(6):1054-9. PubMed ID: 8208399
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 4-Aminopyridine in multiple sclerosis: prolonged administration.
    Stefoski D, Davis FA, Fitzsimmons WE, Luskin SS, Rush J, Parkhurst GW.
    Neurology; 1991 Sep; 41(9):1344-8. PubMed ID: 1891078
    [Abstract] [Full Text] [Related]

  • 14. The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study.
    Smits RC, Emmen HH, Bertelsmann FW, Kulig BM, van Loenen AC, Polman CH.
    Neurology; 1994 Sep; 44(9):1701-5. PubMed ID: 7936300
    [Abstract] [Full Text] [Related]

  • 15. 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
    Sanders DB, Howard JF, Massey JM.
    Ann N Y Acad Sci; 1993 Jun 21; 681():588-90. PubMed ID: 8357206
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.